Shaohua Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shaohua Ma has a total of 313 co-authors. Here are the top co-authors by number of shared publications:
Zitian Wang
Institute of Biopharmaceutical and Health Engineering (iBHE), Tsinghua Shenzhen International Graduate School (SIGS), Tsinghua University, Shenzhen, 518055, China; Key Laboratory of Industrial Biocatalysis, Ministry of Education, Tsinghua University, Beijing, 100084, China; Key Lab of Active Proteins and Peptides Green Biomanufacturing of Guangdong Higher Education Institutes, Tsinghua Shenzhen International Graduate School, Shenzhen, 518055, China
32 shared publicationsHaoran Zhao
Synorg Biotechnology (Shenzhen) Co. Ltd. Shenzhen China
16 shared publicationsYongde Cai
Synorg Biotechnology (Shenzhen) Co. Ltd., Shenzhen 518107, China
16 shared publicationsYu Zhu
Tsinghua Shenzhen International Graduate School (SIGS), Tsinghua University, Shenzhen 518055, China
16 shared publicationsJiyuan Tang
Institute of Biopharmaceutical and Health Engineering (iBHE), Tsinghua Shenzhen International Graduate School (SIGS), Tsinghua University
14 shared publicationsDavit Khutsishvili
Institute of Biopharmaceutical and Health Engineering (iBHE), Tsinghua Shenzhen International Graduate School (SIGS), Tsinghua University, Shenzhen, 518055, China
13 shared publications
Latest Publications
- 4 November 2026
- Published by Elsevier in Biomaterials
- Vol. 339, 124758
Micropatterned hydrogel modulates neuroepithelial organization and neural development in human brain organoids with regulation of YAP1 and BRN2
- 4 November 2026
- Published by Elsevier in Biomaterials
- Vol. 339, 124758
Micropatterned hydrogel modulates neuroepithelial organization and neural development in human brain organoids with regulation of YAP1 and BRN2
- Open Access
- 20 October 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 15
An integrated human forebrain organoid reveals microglia-mediated CD8+ T cell recruitment and neuroimmune dysfunction in Alzheimer’s disease pathology
Genetic evidence implicates immune dysfunction in Alzheimer’s disease (AD), yet the neuroimmune mechanisms operating in human tissue remain poorly defined. Here, we establish a modular human forebrain organoid platform that systematically integrates human induced pluripotent stem cell-derived microglia and CD8 + T cells to reconstitute multicellular AD pathology. This system enables functional interrogation of both innate and adaptive immune components in a human-relevant context. Using this platform, we demonstrate that microglia mediate amyloid-β clearance and neuronal maturation but also drive inflammatory activation and recruit CD8 + T cells through CCL4/5 signaling via CCR1/5 and CXCR3, establishing a neuroinflammatory feedback loop. Pharmacological targeting of CCR5 or CXCR3 blocks T cell recruitment and modulates autophagy in a microglia-dependent manner. This modular organoid platform provides a versatile tool for dissecting neuron–immune interactions and enables cell-type-specific therapeutic screening in human neuroinflammatory disease models.
- 20 October 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 15
Open AccessAn integrated human forebrain organoid reveals microglia-mediated CD8+ T cell recruitment and neuroimmune dysfunction in Alzheimer’s disease pathology
Genetic evidence implicates immune dysfunction in Alzheimer’s disease (AD), yet the neuroimmune mechanisms operating in human tissue remain poorly defined. Here, we establish a modular human forebrain organoid platform that systematically integrates human induced pluripotent stem cell-derived microglia and CD8 + T cells to reconstitute multicellular AD pathology. This system enables functional interrogation of both innate and adaptive immune components in a human-relevant context. Using this platform, we demonstrate that microglia mediate amyloid-β clearance and neuronal maturation but also drive inflammatory activation and recruit CD8 + T cells through CCL4/5 signaling via CCR1/5 and CXCR3, establishing a neuroinflammatory feedback loop. Pharmacological targeting of CCR5 or CXCR3 blocks T cell recruitment and modulates autophagy in a microglia-dependent manner. This modular organoid platform provides a versatile tool for dissecting neuron–immune interactions and enables cell-type-specific therapeutic screening in human neuroinflammatory disease models.
- Open Access
- 7 October 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 15
An integrated human forebrain organoid reveals microglia-mediated CD8⁺ T cell recruitment and neuroimmune dysfunction in Alzheimer’s disease pathology
Genetic evidence implicates immune dysfunction in Alzheimer’s disease (AD), yet the neuroimmune mechanisms operating in human tissue remain poorly defined. Here, we establish a modular human forebrain organoid platform that systematically integrates iPSC-derived microglia and CD8+ T cells to reconstitute multicellular Alzheimer’s disease pathology. This system enables functional interrogation of both innate and adaptive immune components in a human-relevant context. Using this platform, we demonstrate that microglia mediate amyloid-β clearance and neuronal maturation but also drive inflammatory activation and recruit CD8+ T cells through CCL4/5 signaling via CCR1/5 and CXCR3, establishing a neuroinflammatory feedback loop. Pharmacological targeting of CCR5 or CXCR3 blocks T cell recruitment and modulates autophagy in a microglia-dependent manner. This modular organoid platform provides a versatile tool for dissecting neuron–immune interactions and enables cell-type-specific therapeutic screening in human neuroinflammatory disease models.
- 7 October 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 15
Open AccessAn integrated human forebrain organoid reveals microglia-mediated CD8⁺ T cell recruitment and neuroimmune dysfunction in Alzheimer’s disease pathology
Genetic evidence implicates immune dysfunction in Alzheimer’s disease (AD), yet the neuroimmune mechanisms operating in human tissue remain poorly defined. Here, we establish a modular human forebrain organoid platform that systematically integrates iPSC-derived microglia and CD8+ T cells to reconstitute multicellular Alzheimer’s disease pathology. This system enables functional interrogation of both innate and adaptive immune components in a human-relevant context. Using this platform, we demonstrate that microglia mediate amyloid-β clearance and neuronal maturation but also drive inflammatory activation and recruit CD8+ T cells through CCL4/5 signaling via CCR1/5 and CXCR3, establishing a neuroinflammatory feedback loop. Pharmacological targeting of CCR5 or CXCR3 blocks T cell recruitment and modulates autophagy in a microglia-dependent manner. This modular organoid platform provides a versatile tool for dissecting neuron–immune interactions and enables cell-type-specific therapeutic screening in human neuroinflammatory disease models.
- Open Access
- 28 September 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (10) , e71888
GLP‐1R agonist semaglutide protects human forebrain organoids from cholesterol‐induced neurotoxicity
INTRODUCTION: Dysregulated cholesterol metabolism represents a critical metabolic stressor in the central nervous system, contributing to neuronal injury across multiple neurological conditions, including Alzheimer's disease (AD). While glucagon‐like peptide‐1 receptor (GLP‐1R) agonists show neuroprotective potential, their capacity to directly mitigate cholesterol‐induced metabolic stress in human neural cells remains to be established. METHODS: Here, we modeled metabolic stress using human induced pluripotent stem cell–derived forebrain organoids exposed to cholesterol overload. The protective effects of the GLP‐1R agonist semaglutide were characterized by integrating bulk/single‐cell transcriptomics, calcium imaging, and biochemical assays. Furthermore, clinical translatability was supported by mapping organoid expression signatures against human post mortem neurodegenerative brain datasets. RESULTS: Cholesterol overload induced cellular stress and transcriptomic alterations that partially overlapped with AD‐associated signatures. Semaglutide protected neural cells from lipotoxic injury. Intracellularly, GLP‐1R activation engaged the cyclic adenosine 3',5'‐monophosphate–protein kinase A and phosphoinositide 3 kinase–protein kinase B–mechanistic target of rapamycin signaling pathways, consistent with reduced lipid droplet accumulation and oxidative stress. Intercellularly, single‐cell analysis indicated partial preservation of disrupted cellular communication, including the neurotrophic midkine signaling network. Functionally, semaglutide stabilized cellular calcium activity patterns under metabolic stress. DISCUSSION: These findings highlight the role of cholesterol homeostasis in maintaining neuronal integrity and position GLP‐1R signaling as a candidate protective axis under metabolic stress, offering insights into therapeutic strategies for AD and broader neurodegenerative disorders.
- 28 September 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (10) , e71888
Open AccessGLP‐1R agonist semaglutide protects human forebrain organoids from cholesterol‐induced neurotoxicity
INTRODUCTION: Dysregulated cholesterol metabolism represents a critical metabolic stressor in the central nervous system, contributing to neuronal injury across multiple neurological conditions, including Alzheimer's disease (AD). While glucagon‐like peptide‐1 receptor (GLP‐1R) agonists show neuroprotective potential, their capacity to directly mitigate cholesterol‐induced metabolic stress in human neural cells remains to be established. METHODS: Here, we modeled metabolic stress using human induced pluripotent stem cell–derived forebrain organoids exposed to cholesterol overload. The protective effects of the GLP‐1R agonist semaglutide were characterized by integrating bulk/single‐cell transcriptomics, calcium imaging, and biochemical assays. Furthermore, clinical translatability was supported by mapping organoid expression signatures against human post mortem neurodegenerative brain datasets. RESULTS: Cholesterol overload induced cellular stress and transcriptomic alterations that partially overlapped with AD‐associated signatures. Semaglutide protected neural cells from lipotoxic injury. Intracellularly, GLP‐1R activation engaged the cyclic adenosine 3',5'‐monophosphate–protein kinase A and phosphoinositide 3 kinase–protein kinase B–mechanistic target of rapamycin signaling pathways, consistent with reduced lipid droplet accumulation and oxidative stress. Intercellularly, single‐cell analysis indicated partial preservation of disrupted cellular communication, including the neurotrophic midkine signaling network. Functionally, semaglutide stabilized cellular calcium activity patterns under metabolic stress. DISCUSSION: These findings highlight the role of cholesterol homeostasis in maintaining neuronal integrity and position GLP‐1R signaling as a candidate protective axis under metabolic stress, offering insights into therapeutic strategies for AD and broader neurodegenerative disorders.
NCACC maps cross-sample spatial niches and reveals cIgG + epithelial rare cells driving liver cancer invasion
Background: Liver cancer exhibits profound spatial and cellular heterogeneity, contributing to tumour progression, invasion and therapeutic resistance. Emerging evidence suggests that rare low-abundance malignant cell populations residing within discrete tissue niches influence these processes. However, their reliable detection and identification remain challenging due to the limitations of conventional spatial and single-cell transcriptomic analyses, which often rely on single-sample convergence and a lack of cross-cohort reproducibility. Objective: To develop a robust framework for identifying rare malignant cell populations across heterogeneous spatial transcriptomic datasets and to characterise their functional role in liver cancer progression. Design: We developed the Niche Cluster Atlas with Cellular Co-localisation (NCACC), a dual-layer framework integrating spatial organisation with cellular composition to enable cross-sample niche discovery. NCACC was applied to a comprehensive liver cancer transcriptomic atlas to identify rare niche-associated malignant cell populations. Results: NCACC stratified liver cancer tumour architecture into reproducible multicellular niche modules and enabled a tumour-invasive front-enriched rare cancer-derived IgG (cIgG) + epithelial cell population. These cells enhanced proliferative and invasive characteristics and were associated with disease progression. Mechanistic analyses identified a STAT1-dependent cIgG-JAK-STAT signalling axis sustaining the invasive-front phenotype and promoting cIgG + epithelial cell aggressive behaviours. We then combined structure-guided virtual screening with patient-derived organoid validation to identify nordihydroguaiaretic acid and gallic aldehyde as candidate modulators. Conclusion: Our study establishes NCACC as a generalisable framework for high-confidence rare malignant cell identification across heterogeneous spatial transcriptomic cohorts, highlighting the cIgG-JAK-STAT as a therapeutically actionable driver of liver cancer invasion.
NCACC maps cross-sample spatial niches and reveals cIgG + epithelial rare cells driving liver cancer invasion
Background: Liver cancer exhibits profound spatial and cellular heterogeneity, contributing to tumour progression, invasion and therapeutic resistance. Emerging evidence suggests that rare low-abundance malignant cell populations residing within discrete tissue niches influence these processes. However, their reliable detection and identification remain challenging due to the limitations of conventional spatial and single-cell transcriptomic analyses, which often rely on single-sample convergence and a lack of cross-cohort reproducibility. Objective: To develop a robust framework for identifying rare malignant cell populations across heterogeneous spatial transcriptomic datasets and to characterise their functional role in liver cancer progression. Design: We developed the Niche Cluster Atlas with Cellular Co-localisation (NCACC), a dual-layer framework integrating spatial organisation with cellular composition to enable cross-sample niche discovery. NCACC was applied to a comprehensive liver cancer transcriptomic atlas to identify rare niche-associated malignant cell populations. Results: NCACC stratified liver cancer tumour architecture into reproducible multicellular niche modules and enabled a tumour-invasive front-enriched rare cancer-derived IgG (cIgG) + epithelial cell population. These cells enhanced proliferative and invasive characteristics and were associated with disease progression. Mechanistic analyses identified a STAT1-dependent cIgG-JAK-STAT signalling axis sustaining the invasive-front phenotype and promoting cIgG + epithelial cell aggressive behaviours. We then combined structure-guided virtual screening with patient-derived organoid validation to identify nordihydroguaiaretic acid and gallic aldehyde as candidate modulators. Conclusion: Our study establishes NCACC as a generalisable framework for high-confidence rare malignant cell identification across heterogeneous spatial transcriptomic cohorts, highlighting the cIgG-JAK-STAT as a therapeutically actionable driver of liver cancer invasion.
- Open Access
- 27 August 2026
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 6 (11) , e70152
pH‐Responsive Ultrasmall Iron Oxide Nanoassemblies for Activatable T 2 / T 1 Magnetic Resonance Imaging
Magnetic resonance (MR) imaging is a widely used noninvasive diagnostic technique, in which contrast‐enhanced imaging accounts for nearly half of all clinical MRI examinations. Although gadolinium‐based contrast agents are extensively employed, their potential safety concerns have motivated the development of alternative T 1 contrast agents. Ultrasmall iron oxide nanoparticles (USIONs, ≤5 nm) have emerged as promising candidates owing to their spin‐canting effects and high surface‐to‐volume ratio; however, their short circulation time and “always‐on” MR signals result in limited target‐to‐background contrast. Herein, we report a facile pH‐responsive smart nanoassembly for switchable T 2 / T 1 ‐weighted MR imaging. The resulting USIONs/polymer nanoassemblies encapsulate multiple USIONs within a condensed hydrophobic core, leading to enhanced magnetic coupling and dominant T 2 ‐weighted MR contrast under physiological conditions. Upon exposure to acidic conditions, the nanoassemblies undergo pH‐triggered disassembly, releasing monodispersed USIONs and concomitantly activating T 1 ‐weighted MR contrast, as evidenced by a pronounced decrease in the transversal relaxivity/longitudinal relaxivity ( r 2 / r 1 ) ratio from 210 to 66. This work presents a simple and versatile strategy for constructing pH‐responsive organic/inorganic nanoassemblies and provides an in vitro proof‐of‐concept platform for activatable MR imaging.
- 27 August 2026
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 6 (11) , e70152
Open AccesspH‐Responsive Ultrasmall Iron Oxide Nanoassemblies for Activatable T 2 / T 1 Magnetic Resonance Imaging
Magnetic resonance (MR) imaging is a widely used noninvasive diagnostic technique, in which contrast‐enhanced imaging accounts for nearly half of all clinical MRI examinations. Although gadolinium‐based contrast agents are extensively employed, their potential safety concerns have motivated the development of alternative T 1 contrast agents. Ultrasmall iron oxide nanoparticles (USIONs, ≤5 nm) have emerged as promising candidates owing to their spin‐canting effects and high surface‐to‐volume ratio; however, their short circulation time and “always‐on” MR signals result in limited target‐to‐background contrast. Herein, we report a facile pH‐responsive smart nanoassembly for switchable T 2 / T 1 ‐weighted MR imaging. The resulting USIONs/polymer nanoassemblies encapsulate multiple USIONs within a condensed hydrophobic core, leading to enhanced magnetic coupling and dominant T 2 ‐weighted MR contrast under physiological conditions. Upon exposure to acidic conditions, the nanoassemblies undergo pH‐triggered disassembly, releasing monodispersed USIONs and concomitantly activating T 1 ‐weighted MR contrast, as evidenced by a pronounced decrease in the transversal relaxivity/longitudinal relaxivity ( r 2 / r 1 ) ratio from 210 to 66. This work presents a simple and versatile strategy for constructing pH‐responsive organic/inorganic nanoassemblies and provides an in vitro proof‐of‐concept platform for activatable MR imaging.
- Open Access
- 5 August 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 15
An integrated human forebrain organoid reveals microglia-mediated CD8+ T cell recruitment and neuroimmune dysfunction in Alzheimer’s disease pathology
Genetic evidence implicates immune dysfunction in Alzheimer’s disease (AD), yet human-specific neuroimmune mechanisms remain poorly defined. Here, we establish a modular human forebrain organoid platform that systematically integrates iPSC-derived microglia and CD8+ T cells to reconstitute multicellular Alzheimer’s disease pathology. This system enables functional interrogation of both innate and adaptive immune components in a human-relevant context. Using this platform, we demonstrate that microglia mediate amyloid-β clearance and neuronal maturation but also drive inflammatory activation and recruit CD8+ T cells through CCL4/5-CXCL10 signaling via CCR1/5 and CXCR3, establishing a neuroinflammatory feedback loop. Pharmacological targeting of CCR5 or CXCR3 blocks T cell recruitment and modulates autophagy in a microglia-dependent manner. This modular organoid platform provides a versatile tool for dissecting neuron–immune interactions and enables cell-type-specific therapeutic screening in human neuroinflammatory disease models.
- 5 August 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 15
Open AccessAn integrated human forebrain organoid reveals microglia-mediated CD8+ T cell recruitment and neuroimmune dysfunction in Alzheimer’s disease pathology
Genetic evidence implicates immune dysfunction in Alzheimer’s disease (AD), yet human-specific neuroimmune mechanisms remain poorly defined. Here, we establish a modular human forebrain organoid platform that systematically integrates iPSC-derived microglia and CD8+ T cells to reconstitute multicellular Alzheimer’s disease pathology. This system enables functional interrogation of both innate and adaptive immune components in a human-relevant context. Using this platform, we demonstrate that microglia mediate amyloid-β clearance and neuronal maturation but also drive inflammatory activation and recruit CD8+ T cells through CCL4/5-CXCL10 signaling via CCR1/5 and CXCR3, establishing a neuroinflammatory feedback loop. Pharmacological targeting of CCR5 or CXCR3 blocks T cell recruitment and modulates autophagy in a microglia-dependent manner. This modular organoid platform provides a versatile tool for dissecting neuron–immune interactions and enables cell-type-specific therapeutic screening in human neuroinflammatory disease models.
- Open Access
- 17 July 2026
- Published by Elsevier in STAR Protocols
- Vol. 7 (3) , 104706
Protocol for high-throughput droplet-engineered TIL-retaining tumor organoids in triple-negative breast cancer
- 17 July 2026
- Published by Elsevier in STAR Protocols
- Vol. 7 (3) , 104706
Open AccessProtocol for high-throughput droplet-engineered TIL-retaining tumor organoids in triple-negative breast cancer
- 29 June 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (27) , 19515-19531
Thermoresponsive Nanoparticles Hijack Neutrophils In Vivo to In Situ Construct Biohybrids for Enhanced Cancer and Infection Therapy
Neutrophils are an ideal drug carrier because of their specific targeting and effective accumulation at sites of inflammation. However, the clinical application of neutrophils as drug carriers is constrained by the inability to sustain ex vivo culture and their short lifespan. Herein, we developed an in situ construction strategy to fabricate neutrophil-nanoparticle biohybrid systems (NE@NPs) in vivo by specifically hijacking the pro-inflammatory neutrophils in blood using thermoresponsive drug-loaded NPs. The pro-inflammatory neutrophils effectively transport these NPs to the tumor microenvironment across the vascular barriers, followed by the release of the NPs through neutrophil extracellular traps (NETs). Subsequent near-infrared (NIR) light-induced spatiotemporally drug-controlled release improved the therapeutic response. The therapeutic efficacy of in situ-constructed NE@NPs is successfully confirmed using multiple mouse models of cancer, pulmonary, and skin infections. This study illustrates that the in situ construction strategy of neutrophil-NP hybrid systems in vivo may be a promising approach for improving inflammation-associated disease treatment.
- 29 June 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (27) , 19515-19531
Thermoresponsive Nanoparticles Hijack Neutrophils In Vivo to In Situ Construct Biohybrids for Enhanced Cancer and Infection Therapy
Neutrophils are an ideal drug carrier because of their specific targeting and effective accumulation at sites of inflammation. However, the clinical application of neutrophils as drug carriers is constrained by the inability to sustain ex vivo culture and their short lifespan. Herein, we developed an in situ construction strategy to fabricate neutrophil-nanoparticle biohybrid systems (NE@NPs) in vivo by specifically hijacking the pro-inflammatory neutrophils in blood using thermoresponsive drug-loaded NPs. The pro-inflammatory neutrophils effectively transport these NPs to the tumor microenvironment across the vascular barriers, followed by the release of the NPs through neutrophil extracellular traps (NETs). Subsequent near-infrared (NIR) light-induced spatiotemporally drug-controlled release improved the therapeutic response. The therapeutic efficacy of in situ-constructed NE@NPs is successfully confirmed using multiple mouse models of cancer, pulmonary, and skin infections. This study illustrates that the in situ construction strategy of neutrophil-NP hybrid systems in vivo may be a promising approach for improving inflammation-associated disease treatment.